CoraLite®594-conjugated Mammaglobin A Monoclonal antibody
Mammaglobin A Monoclonal Antibody for IF
Host / Isotype
Mouse / IgG1
Reactivity
human
Applications
IF-P
Conjugate
CoraLite®594 Fluorescent Dye
CloneNo.
2E5D4
Cat no : CL594-66237
Synonyms
Validation Data Gallery
Tested Applications
Positive IF-P detected in | human breast cancer tissue |
Recommended dilution
Application | Dilution |
---|---|
Immunofluorescence (IF)-P | IF-P : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
CL594-66237 targets Mammaglobin A in IF-P applications and shows reactivity with human samples.
Tested Reactivity | human |
Host / Isotype | Mouse / IgG1 |
Class | Monoclonal |
Type | Antibody |
Immunogen | Mammaglobin A fusion protein Ag22485 |
Full Name | secretoglobin, family 2A, member 2 |
Calculated Molecular Weight | 93 aa, 10 kDa |
GenBank Accession Number | BC128252 |
Gene Symbol | Mammaglobin A |
Gene ID (NCBI) | 4250 |
RRID | AB_2919969 |
Conjugate | CoraLite®594 Fluorescent Dye |
Excitation/Emission Maxima Wavelengths | 588 nm / 604 nm |
Form | Liquid |
Purification Method | Protein G purification |
Storage Buffer | PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3. |
Storage Conditions | Store at -20°C. Avoid exposure to light. Aliquoting is unnecessary for -20oC storage. |
Background Information
Mammaglobin A, also known as SCGB2A2, is a member of the secretoglobin superfamily. Mammaglobin A is a breast cancer-associated antigen almost exclusively over-expressed in primary and metastatic human breast cancers, making it a specific molecular marker and a potential therapeutic target for breast cancer. This monoclonal antibody is raised against full-length of 93-amino acid human mammaglobin A.
Protocols
Product Specific Protocols | |
---|---|
IF protocol for CL594 Mammaglobin A antibody CL594-66237 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |